Shionogi anuncia la publicación de dos estudios en the Lancet Infectious Diseases que destacan la eficacia y seguridad de cefiderocol en el tratamiento de infecciones debidas a bacterias aeróbicas gram- negativas en adultos
To improve your experience, this website uses cookies for analytics and functionality purposes. More information about how we use cookies and how you can control them is in our Cookie Policy. By continuing to use our website you agree to our use of these cookies.
